Unknown

Dataset Information

0

Bioactive coating provides antimicrobial protection through immunomodulation and phage therapeutics.


ABSTRACT: Medical implant-associated infections (IAI) is a growing threat to patients undergoing implantation surgery. IAI prevention typically relies on medical implants endowed with bactericidal properties achieved through surface modifications with antibiotics. However, the clinical efficacy of this traditional paradigm remains suboptimal, often necessitating revision surgery and posing potentially lethal consequences for patients. To bolster the existing anti-IAI arsenal, we propose herein a chitosan-based bioactive coating, i.e., ChitoAntibac, which exerts bacteria-inhibitory effects either through immune modulation or phage-directed microbial clearance, without relying on conventional antibiotics. The immuno-stimulating effects and phage-induced bactericidal properties can be tailored by engineering the loading dynamic of macrophage migration inhibitory factor (MIF), which polarizes macrophages towards the proinflammatory subtype (M1) with enhanced bacterial phagocytosis, and Staphylococcal Phage K, resulting in rapid and targeted pathogenic clearance (>99.99%) in less than 8 h. Our innovative antibacterial coating opens a new avenue in the pursuit of effective IAI prevention through immuno-stimulation and phage therapeutics.

SUBMITTER: Wu KZ 

PROVIDER: S-EPMC10959705 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bioactive coating provides antimicrobial protection through immunomodulation and phage therapeutics.

Wu Kenny Zhuoran KZ   Le Zhicheng Z   Myint Ba B   Chan Brian B   Liu Ling L   Huang Hua H   Sing Swee Leong SL   Tay Andy A  

Materials today. Bio 20240311


Medical implant-associated infections (IAI) is a growing threat to patients undergoing implantation surgery. IAI prevention typically relies on medical implants endowed with bactericidal properties achieved through surface modifications with antibiotics. However, the clinical efficacy of this traditional paradigm remains suboptimal, often necessitating revision surgery and posing potentially lethal consequences for patients. To bolster the existing anti-IAI arsenal, we propose herein a chitosan-  ...[more]

Similar Datasets

| S-EPMC11873980 | biostudies-literature
2019-04-30 | GSE108718 | GEO
| S-EPMC7940769 | biostudies-literature
| S-EPMC10180540 | biostudies-literature
| S-EPMC6027540 | biostudies-other
| S-EPMC4224336 | biostudies-literature
| S-EPMC6628910 | biostudies-literature
| S-EPMC9256949 | biostudies-literature
2023-01-12 | GSE219119 | GEO
| S-EPMC6022877 | biostudies-literature